Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine
- 30 June 2004
- journal article
- review article
- Published by Elsevier BV in Gastroenterology Clinics of North America
- Vol. 33 (2), 209-234
- https://doi.org/10.1016/j.gtc.2004.02.004
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Genetic Polymorphism of Thiopurine S-Methyltransferase: Molecular Mechanisms and Clinical ImportancePharmacology, 2000
- Immunosuppressive therapy for ulcerative colitis: results of a nation‐wide survey among consultant physician members of the British Society of GastroenterologyAlimentary Pharmacology & Therapeutics, 1999
- Thiopurine methyltransferase alleles in British and Ghanaian populationsHuman Molecular Genetics, 1999
- Polymorphism of the thiopurine S-methyltransferase gene in African- AmericansHuman Molecular Genetics, 1999
- Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*Cancer Cell, 1997
- Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine IntoleranceAnnals of Internal Medicine, 1997
- The clinical pharmacology of 6-mercaptopurineEuropean Journal of Clinical Pharmacology, 1992
- Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphismCancer Cell, 1989
- The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's diseaseJournal of Clinical Immunology, 1985
- AZATHIOPRINE FOR CROHN'S DISEASEThe Lancet, 1969